TOMATO YELLOW LEAF CURL VIRUS INTERGENIC SIRNAS TARGET A HOST LONG NONCODING RNA TO MODULATE DISEASE SYMPTOMS.

Tomato yellow leaf curl virus intergenic siRNAs target a host long noncoding RNA to modulate disease symptoms.

Tomato yellow leaf curl virus (TYLCV) and its related begomoviruses cause fast-spreading diseases in tomato worldwide.How this virus induces diseases remains largely unclear.Here we report a noncoding RNA-mediated model to elucidate the molecular mechanisms of TYLCV-tomato interaction and disease development.The circular ssDNA genome of TYLCV conta

read more

Study of the Chronology of Expression of Ten Extracellular Matrix Molecules during the Myogenesis in Cattle to Better Understand Sensory Properties of Meat

The sensory properties of beef are known to depend on muscle fiber and intramuscular connective tissue composition (IMCT).IMCT is composed of collagens, proteoglycans and glycoproteins.The ANÁLISIS DE LA DISCLOSURE DE LOS REQUERIMIENTOS DE PAGOS PÚBLICOS: INFLUENCIA DE LA LEGISLACIÓN Y FUNDAMENTOS DE LA TEORÍA CONTABLE differentiation of muscle

read more

Knowledge and Behavior-Driven Fruit Fly Optimization Algorithm for Field Service Scheduling Problem with Customer Satisfaction

The field service scheduling problem (FSSP) is the key problem in field services.Field service pays particular attention to customer experience, that is, customer satisfaction.Customer satisfaction described by customer behavior characteristics based on the prospect theory is considered as the primary optimization goal in this paper.The knowledge o

read more

AMAFRICA, a patient-navigator program for accompanying lymphoma patients during chemotherapy in Ivory Coast: a prospective randomized study

Abstract Background Previous Sustainable waste management: international experience for Ukraine regions studies have indicated that accompanying socially underserved cancer patients through Patient Navigator (PN) or PN-derived procedures improves therapy management and reassurance.At the Cancer Institute of Toulouse-Oncopole (France), we have imple

read more